DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

190.38 -0.30 (-0.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JAZZ $190.38 -0.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $190.82
Previous Close $190.68
Daily Range $187.03 - $191.24
52-Week Range $131.69 - $193.85
Market Cap $11.6B
P/E Ratio 52.53
Dividend (Yield) $0.00 (0.0%)
Volume 345,635
Average Daily Volume 426,260
Current FY EPS $8.68




Drug Makers

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary

This Winning Biotech Stock Looks Like a Buy

Jazz Pharmaceuticals is up more than 20-fold over the past five years, and strong growth in the company's narcolepsy drug Xyrem makes this Foolish contributor believe the good times will continue to roll.

Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

ETFs For The Next Pharma Takeover Candidates

EWG, DWAQ: Big ETF Inflows

Insider Trading Alert - RGSE, VLGEA And JAZZ Traded By Insiders

Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ)

Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz

Commit To Buy Jazz Pharmaceuticals At $115, Earn 6.8% Using Options

40% Return In ~4 Months With Our IP Selected Healthcare Companies Since SA Publication

Jazz Pharmaceuticals (JAZZ) Shares Cross Below 200 DMA

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $190.38 (-0.16%)
Current stock: JAZZ
JNJ $99.84 (0.11%)
Current stock: JNJ
NVS $103.18 (-0.49%)
Current stock: NVS
RHHBY $36.05 (-0.11%)
Current stock: RHHBY